Back to search results
NCT07634419

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Duke University
~450 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:Lift mobile mindfulnessEnlighten Recovery education program

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Health Questionnaire 9-item depression scale (PHQ-9)
Measured over Baseline to 1 month

Conditions

Critical Illness
Heart Failure
Sepsis
Ards
Pneumonia
Trauma Injury

Explore related trials

Critical IllnessHeart FailureInjuryPneumoniaPsychological DistressRespiratory Distress Syndrome, AcuteSepticemia

NCT07634419

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cedars-Sinai Medical Center

    Los Angeles, Californiastudy coordinator listed

  • Duke University Medical Center

    Durham, North Carolinano site contact published

  • Medical University of South Carolina

    Charleston, South Carolinano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Christopher Cox, MD, MHA, MPH · PRINCIPAL_INVESTIGATOR · Duke University

Who to contact

Kristy Johnson
[email protected]
9196817232
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

mechanical ventilation via endotracheal tube for ≥4 hours
non-invasive ventilation (CPAP, BiPAP) for ≥4 hours in a 24-hour period provided for acute respiratory failure
new use of supplemental oxygen ≥6 liters per minute (or increase in baseline continuous oxygen)
use of vasopressors for shock of any etiology
use of inotropes for shock of any etiology
use of pulmonary vasodilators
use of aortic balloon pump or cardiac assist device for cardiogenic shock
use of diuretic intravenous drip
evidence of acute coronary ischemia (i.e., elevated troponin level, supporting EKG changes, unstable angina symptoms documented)
urgent cardiac catheterization 4. Cognitive status intact

What this trial measures

  • Patient Health Questionnaire 9-item depression scale (PHQ-9)Baseline to 1 month

    The PHQ-9 is a primary trial outcome measure and the PHQ-9 score at 1 month is the primary trial outcome (Kroenke K, et al. J Gen Intern Med 606-13, 2001). The PHQ-9 is a well-validated metric with English and Spanish versions used in thousands of RCTs. Scores can range from 0 (no depression symptoms) to 27 (serious depression symptoms). The PHQ-9 MCID is 2-4 units.